AMEX: MTNB       Matinas Biopharma Hl
Last Price Today's Change   Day's Range   Trading Volume
0.399   +0.006 (1.53%)  0.39 - 0.42  245,600


Avg Volume (4 weeks):557,018
4 Weeks Range:0.379 - 0.69
4 Weeks Price Volatility (%):
52 Weeks Range:0.379 - 0.94
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphotericin B and other clinical stage product candidate is MAT2501 which is a an orally administered, encochleated formulation of the broad spectrum aminoglycoside antibiotic amikacin which treats different types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections as well as various multidrug-resistant gram negative and intracellular bacterial infections.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6687  2946  917  902 

Top 10 Active Counters
 TSLA 213.97+6.45 
 SQQQ 21.74-0.48 
 TQQQ 36.82+0.81 
 T 15.21-0.60 
 UTRS 0.293+0.093 
 MMV 2.04+1.09 
 SPY 427.92+6.10 
 YJ 0.32+0.108 
 PLTR 14.52-0.02 
 BAC 28.71+0.93